๐Ÿšง Under construction โ€” Data may be inaccurate. We are actively adding more companies and metrics.
IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc.

IDXXโ€ขRank #269โ€ขHealthcareโ€ขDiagnostics & Research

Market Cap

$46.2B

Global Rank

#269

All-Time High

$53.4B

2025-12-31

Total Growth

+0%

since 2026

Market Cap Context

  • Larger than 27% of the 367 companies we track (globally).
  • Equivalent to 0.2% of United States's GDP (2025 data).
  • Just above: #268 eBay Inc. ($47.2B)
  • Just below: #270 Thomson Reuters Corporation ($46.2B)
  • Best year: 1995 (+161%). Worst year: 1997 (-56%).

IDEXX Laboratories, Inc. Financial Breakdown (FY 2025)

Source: Yahoo Finance โ€” IDXX annual filings (2025) โ†’

$4.3B revenue ยท $1.4B operating income ยท $1.1B net income

  • โ—Operating margin: 31.6% on $4.3B in revenue.
  • โ—R&D is 5.8% of revenue ($0.3B).
  • โ—Net income margin: 24.6% โ€” $1.1B in profit.
  • โ—Free cash flow: $1.0B (24.2% of revenue).

Cost / Operating Expenses

Total operating expenses $2.9B

Total

$2.9B

Cost of revenueยท Product / service delivery costs (COGS)$1.6B55.8%
Research & development$0.3B8.5%
Sales & marketing$0.6B21.9%
General & administrative$0.4B13.8%

Capital Expenditures

$0.1B

This fiscal year (near-total AI infrastructure buildout)

Free Cash Flow

$1.0B

Trailing twelve months

Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs about 11,000 people in full-and part-time positions.

IDEXX Laboratories, Inc. Market Cap History (2026โ€“2026)

IDEXX Laboratories, Inc. vs Sector Peers by Market Cap

Takeda Pharmaceutical Company Limited4502.T
$59.7B
Becton, Dickinson and CompanyBDX
$49.4B
IDEXX Laboratories, Inc.IDXX
$46.2B
Humana Inc.HUM
$44.8B
CSL LimitedCSL.AX
$43.1B
Veeva Systems Inc.VEEV
$38.4B
DexCom, Inc.DXCM
$33.8B
Zoetis Inc.ZTS
$31.1B

Compare IDEXX Laboratories, Inc.

Ranking History

YearMarket CapRankYoY Change
2026$46.2B#269(โ†“29)-13.4%
2025$53.4B#240(โ†‘55)+63.6%
2024$32.6B#295(โ†“57)-25.5%
2023$43.8B#238(โ†‘23)+36.1%
2022$32.2B#261(โ†“63)-38.0%
2021$51.9B#198(โ†‘10)+31.7%
2020$39.4B#208(โ†‘67)+91.4%
2019$20.6B#275(โ†“5)+40.4%
2018$14.7B#270(โ†‘9)+19.0%
2017$12.3B#279(โ†“1)+33.4%
2016$9.3B#278(โ†‘6)+60.8%
2015$5.8B#284(โ†“3)-1.6%
2014$5.8B#281(โ†‘3)+39.4%
2013$4.2B#284(โ†“6)+14.6%
2012$3.7B#278(โ†“7)+20.6%
2011$3.0B#271(โ†‘1)+11.2%
2010$2.7B#272(โ†“4)+29.5%
2009$2.1B#268(โ†“3)+48.1%
2008$1.4B#265(โ†“1)-38.5%
2007$2.3B#264(โ†“4)+47.9%
2006$1.6B#260(โ†“1)+10.2%
2005$1.4B#259(โ†“9)+31.9%
2004$1.1B#250(โ†“3)+18.0%
2003$912.7M#247(โ†“5)+40.9%
2002$647.8M#242(โ†“1)+15.2%
2001$562.2M#241(โ†“13)+29.6%
2000$433.9M#228(โ†“36)+36.4%
1999$318.0M#192(โ†“13)-40.1%
1998$530.6M#179(โ†“6)+68.8%
1997$314.3M#173(โ†“19)-55.7%
1996$709.9M#154(โ†“18)-23.4%
1995$926.9M#136(โ†“4)+161.1%
1994$355.0M#132

Other Healthcare Companies

FAQ

What is IDEXX Laboratories, Inc.'s market cap?

IDEXX Laboratories, Inc. (IDXX) has a market capitalization of $46.2B, making it the #269 largest company in the world by market cap.

What was IDEXX Laboratories, Inc.'s highest market cap?

IDEXX Laboratories, Inc.'s all-time high market cap was $53.4B, reached in 2025-12-31. Its highest rank was #240 in 2025.

What sector is IDEXX Laboratories, Inc. in?

IDEXX Laboratories, Inc. is in the Healthcare sector, specifically the Diagnostics & Research industry. It is based in United States.

How has IDEXX Laboratories, Inc.'s market cap changed over time?

IDEXX Laboratories, Inc. has been tracked since 2026. Its market cap has grown by 0% from $46.2B in 2026 to $46.2B today.